Maraganore’s exit tasks Greenstreet with Alnylam’s five-year plan
COO Greenstreet, a pharma vet, to ascend after five years at Alnylam
With John Maraganore’s departure from Alnylam, incoming CEO Yvonne Greenstreet will be tasked with leading the company’s execution on its goals of continuing its fast-growing commercial expansion and attaining a top-five market cap in its category by 2025.
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) said Thursday that Maraganore will step down as CEO at year-end, more than 19 years after he arrived at the then-nascent RNAi company. Succeeding him will be Greenstreet, who joined as EVP and COO in 2016 and became president and COO last year...
BCIQ Company Profiles
BCIQ Target Profiles